Autologous Muscle Derived Cells

BIOLOGICAL2 trials

Sponsors

Cook MyoSite, Jason Gilleran

Conditions

Stress Urinary IncontinenceUrinary IncontinenceUrinary Retention

Phase 1

Autologous Muscle Derived Cells for Underactive Bladder

CompletedNCT02463448

Jason GilleranUrinary Incontinence, Urinary Retention

Start: 2016-11-16End: 2020-11-30Updated: 2022-01-19

Phase 2

Autologous Cell Therapy for Female Stress Urinary Incontinence

CompletedNCT01008943

Cook MyoSiteStress Urinary Incontinence

Start: 2010-06-02End: 2012-09-21Updated: 2021-07-01

Related Papers

PD21-07 URINARY MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1/CCL2) EXPRESSION AS AN INDICATOR OF GLOBAL RESPONSE ASSESSMENT IN CLINICAL TRIAL FOR UNDERACTIVE BLADDER (UAB)

The Journal of Urology2020-04-01

LBA-04 INTRADETRUSOR INJECTION OF ADULT MUSCLE-DERIVED CELLS FOR THE TREATMENT OF UNDERACTIVE BLADDER: INTERIM REPORT ON SAFETY AND EFFICACY (NCT02463448)

The Journal of Urology2019-04-013 citations

PD50-08 AUTOLOGOUS MUSCLE DERIVED CELLS FOR URINARY SPHINCTER REPAIR FOR RECURRENT OR PERSISTENT STRESS URINARY INCONTINENCE AFTER CONTINENCE SURGERY

The Journal of Urology2017-04-014 citations